Download
s00277-021-04547-3.pdf 1,12MB
WeightNameValue
1000 Titel
  • Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
1000 Autor/in
  1. petrides, petro |
  2. Klein, Michael |
  3. Schuhmann, Elfriede |
  4. Torkler, Heike |
  5. Molitor, Brigitte |
  6. Loehr, Christian |
  7. Obermeier, Zahra |
  8. Beykirch, Maria K. |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-05-29
1000 Erschienen in
1000 Quellenangabe
  • 100(7):1685-1693
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00277-021-04547-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195940/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Givosiran is a novel approach to treat patients with acute intermittent porphyrias (AIP) by silencing of ∂-ALA-synthase 1, the first enzyme of heme biosynthesis in the liver. We included two patients in the Envision study who responded clinically well to this treatment. However, in both patients, therapy had to be discontinued because of severe adverse effects: One patient (A) developed local injection reactions which continued to spread all over her body with increasing number of injections and eventually caused a severe systemic allergic reaction. Patient B was hospitalized because of a fulminant pancreatitis. Searching for possible causes, we also measured the patients plasma homocysteine (Hcy) levels in fluoride-containing collection tubes: by LC-MS/MS unexpectedly, plasma Hcy levels were 100 and 200 in patient A and between 100 and 400 μmol/l in patient B. Searching for germline mutations in 10 genes that are relevant for homocysteine metabolism only revealed hetero- and homozygous polymorphisms in the MTHFR gene. Alternatively, an acquired inhibition of cystathionine-beta-synthase which is important for homocysteine metabolism could explain the plasma homocysteine increase. This enzyme is heme-dependent: when we gave heme arginate to our patients, Hcy levels rapidly dropped. Hence, we conclude that inhibition of ∂-ALA-synthase 1 by givosiran causes a drop of free heme in the hepatocyte and therefore the excessive increase of plasma homocysteine. Hyperhomocysteinemia may contribute to the adverse effects seen in givosiran-treated patients which may be due to protein-N-homocysteinylation.
1000 Sacherschließung
lokal Heme/therapeutic use [MeSH]
lokal Hyperhomocysteinemia/etiology [MeSH]
lokal Porphyria, Acute Intermittent/blood [MeSH]
lokal Models, Biological [MeSH]
lokal Heme/analysis [MeSH]
lokal Original Article
lokal Acetylgalactosamine/adverse effects [MeSH]
lokal Male [MeSH]
lokal Porphyria, Acute Intermittent/genetics [MeSH]
lokal Pyrrolidines/adverse effects [MeSH]
lokal Acute porphyria
lokal Colon, Sigmoid/pathology [MeSH]
lokal Pyrrolidines/therapeutic use [MeSH]
lokal Hydroxymethylbilane Synthase/blood [MeSH]
lokal Hepatocytes/drug effects [MeSH]
lokal Drug Hypersensitivity/etiology [MeSH]
lokal Female [MeSH]
lokal Colitis/etiology [MeSH]
lokal Acetylgalactosamine/analogs
lokal Heme/deficiency [MeSH]
lokal Fibrosis [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Arginine/therapeutic use [MeSH]
lokal Free heme
lokal Acetylgalactosamine/therapeutic use [MeSH]
lokal Hydroxymethylbilane Synthase/genetics [MeSH]
lokal ∂-ALA-Synthase 1
lokal Hepatocytes/metabolism [MeSH]
lokal N-homocysteinylation
lokal Severe homocysteinemia
lokal Homocysteine/metabolism [MeSH]
lokal Controlled Clinical Trials as Topic [MeSH]
lokal 5-Aminolevulinate Synthetase/antagonists
lokal Porphyria, Acute Intermittent/drug therapy [MeSH]
lokal Pancreatitis/etiology [MeSH]
lokal Givosiran
lokal High-Throughput Nucleotide Sequencing [MeSH]
lokal Porphyria, Acute Intermittent/complications [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-1554-8266|https://frl.publisso.de/adhoc/uri/S2xlaW4sIE1pY2hhZWw=|https://frl.publisso.de/adhoc/uri/U2NodWhtYW5uLCBFbGZyaWVkZQ==|https://frl.publisso.de/adhoc/uri/VG9ya2xlciwgSGVpa2U=|https://frl.publisso.de/adhoc/uri/TW9saXRvciwgQnJpZ2l0dGU=|https://frl.publisso.de/adhoc/uri/TG9laHIsIENocmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/T2Jlcm1laWVyLCBaYWhyYQ==|https://frl.publisso.de/adhoc/uri/QmV5a2lyY2gsIE1hcmlhIEsu
1000 Hinweis
  • DeepGreen-ID: 7042139028734bb191cc825b3dc2916a ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6447815.rdf
1000 Erstellt am 2023-05-03T16:31:00.471+0200
1000 Erstellt von 322
1000 beschreibt frl:6447815
1000 Zuletzt bearbeitet Fri Oct 20 21:21:25 CEST 2023
1000 Objekt bearb. Fri Oct 20 21:21:25 CEST 2023
1000 Vgl. frl:6447815
1000 Oai Id
  1. oai:frl.publisso.de:frl:6447815 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source